Sign in to view content

Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials

Diana V Do, MD, FASRS

Video
Published 2019

Diana V. Do, MD

Retinal Vascular Disease Symposium

Related

Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2021
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018
Diabetic Retinopathy 2 Symposium
Annual Meeting Talks
2020

Category: Retinal Vascular Disease

See more